Inhibitor Therapeutics, Inc.

OTC:INTI
Annual Meeting

of Shareholders

MEETING DATE

09/15/2026
DEF 14A FILED
08/17/2026
PUBLISHED
08/17/2026 12:00 pm
TIME TO PUBLISH
08/19/2026
METHODOLOGY
approve
EXCHANGE OTC:INTI· CUSIP · CLASS Common Stock · CIK 0001042418

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

6
FOR
0
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Director Election Proposal
board
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Board nominated six incumbent directors for election to terms expiring at the 2027 annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Auditor Ratification Proposal
auditor
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Audit Committee received Cherry independence disclosures and discussed Cherry's independence with the auditor.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Incentive Plan Proposal
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

If stockholders do not approve the 2025 Plan, it will not become effective and no awards will be granted.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Say-on-Pay Proposal
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The proposal seeks advisory approval of executive compensation disclosed in the compensation tables and related narrative discussion.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Frequency Proposal
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Board recommends a three-year interval for future advisory votes on executive compensation.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Adjournment Proposal
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The proposal permits adjournment to solicit additional proxies if votes are insufficient to approve other proposals.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

9be27176a0a33eda4ebdc1bacef71fdb5a7befbbb7f25528cd3215de375166f9

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates